Deferred Tax Assets, Valuation Allowance of ANAPTYSBIO, INC from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ANAPTYSBIO, INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • ANAPTYSBIO, INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $192,638,000, a 2.9% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ANAPTYSBIO, INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $192,638,000 +$5,453,000 +2.9% 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q4 2024 $187,185,000 +$35,818,000 +24% 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q4 2023 $151,367,000 +$34,797,000 +30% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $116,570,000 +$30,366,000 +35% 31 Dec 2022 10-K 11 Mar 2024 2023 FY
Q4 2021 $86,204,000 +$4,870,000 +6% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q4 2020 $81,334,000 +$6,851,000 +9.2% 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q4 2019 $74,483,000 +$26,895,000 +57% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $47,588,000 +$23,778,000 +100% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q4 2017 $23,810,000 +$4,515,000 +23% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q4 2016 $19,295,000 31 Dec 2016 10-K 05 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.